Grants / Department of Health and Human Services / Centers for Disease Control and Prevention - ERA

RFA-CE-24-011: Grants to Support New Investigators in Conducting Research Related to Understanding Drug Use and Overdose Risk and Protective Factors (K01)

Closed Closed December 1, 2023 Opportunity RFA-CE-24-011 ☆ Save

This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2023.

• Award ceiling$150,000
• Total funding$1.4 million
• Expected awards3
• Cost sharingNot required
• Funding typeGrant

Key dates

Who can apply

This opportunity was open to any type of organization.

See Section III. Eligibility Information.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Past Injury Prevention and Control Research and State and Community Based Programs awards averaged $2.2 million; this notice allows up to $150,000 per award.
• Most of the program's money (76% over five years) went to state and local governments.
• No cost sharing or match is required.

What the grant funds

The purpose of the Centers for Disease Control and Prevention National Center for Injury Prevention and Control (NCIPC) Mentored Research Scientist Development Award (K01) is to provide support for an intensive, supervised/mentored career development experience in substance use and/or overdose prevention research leading to research independence. NCIPC supports K01 grants to help ensure the availability of an adequate number of trained scientists to address critical public health research questions to prevent polydrug use and overdose. This funding would support research that aims to better understand and identify risk and protective factors related to any drug use/overdose (e.g., opioids including fentanyl and stimulants, etc.), substance use disorders (SUDs), and stigma (e.g., how do certain factors impact stigma). Research can focus on the examination of potential moderators or mediators between the relationship between risk and protective factors and drug use and outcomes. Research should be conducted among persons experiencing a disproportionate burden of substance use disorders and overdose, which may include but are not limited, to those people in certain sociodemographic groups (e.g. non-English speaking populations, tribal populations, rural communities, racial/ethnic minority groups, sexual and gender minority groups), people experiencing social determinants of health (e.g., reduced economic stability; limited educational attainment, access or quality; limited healthcare access or quality including those who have been historically underserved or are uninsured; limited access to substance use treatment; limited health literacy; those in geographically underserved areas), people experiencing social or physical health conditions or experiences (e.g., homelessness, a mental health condition, chronic pain, incarceration or recent release from incarceration, a disability, adverse childhood experiences, a history of suicidal ideation or suicide attempt, a history of substance use disorders and/or overdose).

Category: Health.

Applying now

This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.